Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR3913] to BRG1 - BSA and Azide free
  • Suitable for: WB
  • Knockout validated
  • Reacts with: Mouse, Human

Overview

  • Product name

    Anti-BRG1 antibody [EPR3913] - BSA and Azide free
    See all BRG1 primary antibodies

  • Description

    Rabbit monoclonal [EPR3913] to BRG1 - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    WB
    Human
    See all applications and species data

  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • General notes

    ab247569 is the carrier-free version of ab92496 This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    Ab247569 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Western blot - Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)
    Western blot - Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)

    This data was developed using ab92496, the same antibody clone in a different buffer formulation.

    Lane 1: Wild-type HAP1 cell lysate (20 µg)

    Lane 2: BRG1 knockout HAP1 cell lysate (20 µg)

    Lane 3: K562 cell lysate (20 µg)

    Lane 4: Molt-4 cell lysate (20 µg)

    Lanes 1 - 4: Merged signal (red and green). Green - ab92496 observed at 185 kDa. Red - loading control, ab18058, observed at 124 kDa.

    ab92496 was shown to recognize BRG1 when BRG1 knockout samples were used, along with additional cross-reactive bands. Wild-type and BRG1 knockout samples were subjected to SDS-PAGE. ab92496 and ab18058 (loading control to Vinculin) were diluted 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)
    Western blot - Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)
    All lanes : Anti-BRG1 antibody [EPR3913] (ab92496) at 1/1000 dilution

    Lane 1 : K562 cell lysate
    Lane 2 : MOLT4 cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : goat anti-rabbit HRP at 1/2000 dilution

    Predicted band size: 185 kDa



    This data was developed using ab92496, the same antibody clone in a different buffer formulation.

     

  • Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)
    Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-BRG1 antibody [EPR3913] - BSA and Azide free (ab247569)

© 2021 Astana Biomed Group LLP. All rights reserved.